Quantcast

Latest Lucentis Stories

2008-09-01 12:00:20

DR McGONAGLE'S put-down of NICE (Letters, August 28) as the "National Institute of Complete Embarrassment" does a disservice. NICE has produced final guidance for the drug Lucentis, now accepted for use throughout the UK. It slows age-related macular degeneration (AMD) which gradually destroys central vision, making reading or driving difficult or impossible. This is clearly not a trivial problem - but neither are the processes required to ensure fairness when deriving priorities for use...

2008-08-29 03:00:10

WASHINGTON - What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing $60 per treatment and the other $2,000? In the case of Genentech Inc., nothing. The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance - or cooperate with - a National Eye Institute study comparing the...

08437c12a373722e7aef749237ef41041
2008-08-28 09:05:00

By Kevin Freking Associated Press What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000? In the case of Genentech Inc., nothing. The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance -- or cooperate with -- a National Eye...

2008-08-28 06:01:10

The National Institute for Health and Clinical Excellence has recommended Novartis's Lucentis as a cost-effective therapy for all eligible patients with wet age-related macular degeneration. The announcement is said to be an important development for patients because the National Institute for Health and Clinical Excellence (NICE) determines access to medicines in England and Wales based on agreed standards of cost-effectiveness. The final guidance comes at the end of a rigorous review...

2008-08-28 03:00:19

THOUSANDS of people all over the country will be able to receive sightsaving drugs thanks to a campaign spearheaded by three Warwickshire patients. The drug Lucentis will now be available on the NHS to anyone with 'wet' macular degeneration - an eye disease which sends sufferers blind. The National Institute for Health and Clinical Excellence (Nice) recommended doctors use the drug because it could cut the cost of treating a patient by more than pounds 8,000 over ten years. Campaigners...

2008-08-28 00:00:38

By Paul Greaves A war veteran who fought a campaign to get a sight-saving drug on the NHS says he feels "vindicated" it will now be made freely available across the country. The National Institute for Health and Clinical Excellence (Nice) has recommended the drug Lucentis be provided free of charge to people with wet age-related macular degeneration (AMD). Former pilot Jack Tagg, 88, from Torquay, Devon, visited Downing Street earlier this year to protest about a decision by his local...

2008-08-28 00:00:37

By JULIA BRADSHAW People who face going blind will now have access to a sight- saving drug on the NHS following a massive campaign to make the medication more widely available. The National Institute for Health and Clinical Excellence has today published guidelines instructing primary care trusts in England and health boards in Wales to fund the drug Lucentis for patients who have wet age- related macular degeneration in either eye. But patients across Devon have already been...

2008-08-27 06:00:48

By Mike Waites Health Correspondent The National Institute for Clinical Excellence (Nice) has backed NHS treatment using the drug Lucentis for the devastating eye condition wet age-related macular degeneration (AMD) following a two- and-half-year battle by patients.The Yorkshire Post revealed last month that people affected by the condition in the region are already being treated using the drug but the decision means the national postcode lottery of care will now end.The disease is the...

2008-08-27 00:00:44

By Jane Kirby Thousands OF people with a devastating eye disease could have their sight saved by a new drug being made available on the NHS, under guidelines published today. The National Institute for Health and Clinical Excellence (Nice) has recommended the drug Lucentis, which is already approved in Scotland, after performing a u-turn on draft guidance published last year. The move was welcomed by the Royal National Institute for the Blind (RNIB), which has campaigned for Lucentis...

2008-07-12 00:00:29

Three elderly patients have launched a landmark High Court challenge over an NHS trust's "absolutely ridiculous" refusal to fund potentially sight-saving treatment. Backed by the Royal National Institute of Blind People (RNIB), they are asking a judge to rule that Warwickshire healthcare chiefs acted "unlawfully and irrationally" in refusing to pay for the drug Ranibizumab, better known under its trade name Lucentis, which is available elsewhere. The sight of all three is threatened by...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related